These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 32823038)

  • 1. Regulatory T cell therapy: Current and future design perspectives.
    Rana J; Biswas M
    Cell Immunol; 2020 Oct; 356():104193. PubMed ID: 32823038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.
    Zhang Q; Lu W; Liang CL; Chen Y; Liu H; Qiu F; Dai Z
    Front Immunol; 2018; 9():2359. PubMed ID: 30369931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance.
    Muller YD; Ferreira LMR; Ronin E; Ho P; Nguyen V; Faleo G; Zhou Y; Lee K; Leung KK; Skartsis N; Kaul AM; Mulder A; Claas FHJ; Wells JA; Bluestone JA; Tang Q
    Front Immunol; 2021; 12():686439. PubMed ID: 34616392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?
    Janssens I; Cools N
    Cell Immunol; 2020 Dec; 358():104236. PubMed ID: 33137651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Building a CAR-Treg: Going from the basic to the luxury model.
    Rosado-Sánchez I; Levings MK
    Cell Immunol; 2020 Dec; 358():104220. PubMed ID: 33096321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Future of Regulatory T Cell Therapy: Promises and Challenges of Implementing CAR Technology.
    Mohseni YR; Tung SL; Dudreuilh C; Lechler RI; Fruhwirth GO; Lombardi G
    Front Immunol; 2020; 11():1608. PubMed ID: 32793236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression.
    De Paula Pohl A; Schmidt A; Zhang AH; Maldonado T; Königs C; Scott DW
    Cell Immunol; 2020 Dec; 358():104222. PubMed ID: 33053469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.
    Tenspolde M; Zimmermann K; Weber LC; Hapke M; Lieber M; Dywicki J; Frenzel A; Hust M; Galla M; Buitrago-Molina LE; Manns MP; Jaeckel E; Hardtke-Wolenski M
    J Autoimmun; 2019 Sep; 103():102289. PubMed ID: 31176558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations.
    Terry LV; Oo YH
    Front Immunol; 2020; 11():565518. PubMed ID: 33072105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Driving CARs to BARs: The Winding Road to Specific Regulatory T Cells for Tolerance.
    Scott DW
    Front Immunol; 2021; 12():742719. PubMed ID: 34552599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology.
    Koristka S; Kegler A; Bergmann R; Arndt C; Feldmann A; Albert S; Cartellieri M; Ehninger A; Ehninger G; Middeke JM; Bornhäuser M; Schmitz M; Pietzsch J; Akgün K; Ziemssen T; Steinbach J; Bachmann MP
    J Autoimmun; 2018 Jun; 90():116-131. PubMed ID: 29503042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specificity using chimeric antigen receptors: the future of regulatory T-cell therapy?
    Boardman D; Maher J; Lechler R; Smyth L; Lombardi G
    Biochem Soc Trans; 2016 Apr; 44(2):342-8. PubMed ID: 27068938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation.
    Selck C; Dominguez-Villar M
    Front Immunol; 2021; 12():661875. PubMed ID: 34054826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory CAR-T cells in autoimmune diseases: Progress and current challenges.
    Riet T; Chmielewski M
    Front Immunol; 2022; 13():934343. PubMed ID: 36032080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric antigen receptor T
    Eskandari SK; Daccache A; Azzi JR
    Trends Immunol; 2024 Jan; 45(1):48-61. PubMed ID: 38123369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional effects of chimeric antigen receptor co-receptor signaling domains in human regulatory T cells.
    Dawson NAJ; Rosado-Sánchez I; Novakovsky GE; Fung VCW; Huang Q; McIver E; Sun G; Gillies J; Speck M; Orban PC; Mojibian M; Levings MK
    Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32817364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How antigen specificity directs regulatory T-cell function: self, foreign and engineered specificity.
    Hoeppli RE; MacDonald KG; Levings MK; Cook L
    HLA; 2016 Jul; 88(1-2):3-13. PubMed ID: 27256587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treg Enhancing Therapies to Treat Autoimmune Diseases.
    Eggenhuizen PJ; Ng BH; Ooi JD
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells.
    Dawson NA; Lamarche C; Hoeppli RE; Bergqvist P; Fung VC; McIver E; Huang Q; Gillies J; Speck M; Orban PC; Bush JW; Mojibian M; Levings MK
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30753169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAR- and TRuC-redirected regulatory T cells differ in capacity to control adaptive immunity to FVIII.
    Rana J; Perry DJ; Kumar SRP; Muñoz-Melero M; Saboungi R; Brusko TM; Biswas M
    Mol Ther; 2021 Sep; 29(9):2660-2676. PubMed ID: 33940160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.